These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 17077980)

  • 1. [Heart rate reduction as a therapeutic strategy: novel options].
    Hoppe UC
    Internist (Berl); 2006 Dec; 47(12):1289-93. PubMed ID: 17077980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease.
    DiFrancesco D; Camm JA
    Drugs; 2004; 64(16):1757-65. PubMed ID: 15301560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ivabradine -- a novel approach for heart rate lowering].
    Er F; Hoppe UC
    Dtsch Med Wochenschr; 2005 Jun; 130(24):1501-2. PubMed ID: 15942839
    [No Abstract]   [Full Text] [Related]  

  • 4. Ivabradine: beyond heart rate control.
    Riccioni G; Vitulano N; D'Orazio N
    Adv Ther; 2009 Jan; 26(1):12-24. PubMed ID: 19165437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ivabradine -- the first selective sinus node I(f) channel inhibitor in the treatment of stable angina.
    Sulfi S; Timmis AD
    Int J Clin Pract; 2006 Feb; 60(2):222-8. PubMed ID: 16451297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Symptomatic coronary heart disease. Therapy with a beta blocker and ivabradine combination].
    MMW Fortschr Med; 2014 Jun; 156(11):58-9. PubMed ID: 25022105
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical results of I(f) current inhibition by ivabradine.
    Tardif JC
    Drugs; 2007; 67 Suppl 2():35-41. PubMed ID: 17999562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart rate slowing versus other pharmacological antianginal strategies.
    Diaz A; Tardif JC
    Adv Cardiol; 2006; 43():65-78. PubMed ID: 16936473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate control with ivabradine: angina pectoris and beyond.
    Parakh N; Bhargava B
    Am J Cardiovasc Drugs; 2011; 11(1):1-12. PubMed ID: 21090826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ivabradine in chronic stable angina: Effects by and beyond heart rate reduction.
    Camici PG; Gloekler S; Levy BI; Skalidis E; Tagliamonte E; Vardas P; Heusch G
    Int J Cardiol; 2016 Jul; 215():1-6. PubMed ID: 27104917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ivabradine: I(f) inhibition in the management of stable angina pectoris and other cardiovascular diseases.
    Tardif JC
    Drugs Today (Barc); 2008 Mar; 44(3):171-81. PubMed ID: 18536779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The efficacy of ivabradine in chronic heart failure (review)].
    Isakadze A; Makharadze T; Gvishiani M
    Georgian Med News; 2015 Apr; (241):44-9. PubMed ID: 25953938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Ivabradine in the Management of Angina Pectoris.
    Giavarini A; de Silva R
    Cardiovasc Drugs Ther; 2016 Aug; 30(4):407-417. PubMed ID: 27475447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
    Ruzyllo W; Tendera M; Ford I; Fox KM
    Drugs; 2007; 67(3):393-405. PubMed ID: 17335297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Use and Indication of Ivabradine in Heart Failure.
    Dodd K; Lampert BC
    Heart Fail Clin; 2018 Oct; 14(4):493-500. PubMed ID: 30266358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ivabradine for chronic heart failure?
    Drug Ther Bull; 2012 Oct; 50(10):117-20. PubMed ID: 23065752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective and specific I(f) inhibition: new perspectives for the treatment of stable angina.
    Fox K
    Expert Opin Pharmacother; 2006 Jun; 7(9):1211-20. PubMed ID: 16732707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of reducing heart rate in cardiovascular diseases: effects of Ivabradine.
    Vizzardi E; Bonadei I; D'Aloia A; Del Magro F; Piovanelli B; Bontempi L; Curnis A; Dei Cas L
    Minerva Med; 2011 Oct; 102(5):373-9. PubMed ID: 22193347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focus on ivabradine: a new heart rate-controlling drug.
    Riccioni G
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):107-13. PubMed ID: 19210206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart rate reduction in heart failure: ivabradine or beta blockers?
    Guglin M
    Heart Fail Rev; 2013 Jul; 18(4):517-28. PubMed ID: 22972475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.